C 2022

Characterization of Clinical-Grade Stem Cells: Microscopic, Cellular, Molecular, and Functional Characterization of Stem Cells and Their Products According to Regulatory Requirements for FDA Approval

SOURALOVÁ, Tereza, Daniela ŘEHÁKOVÁ, Lenka TESAŘOVÁ, Aleš HAMPL, Irena KOUTNÁ et. al.

Basic information

Original name

Characterization of Clinical-Grade Stem Cells: Microscopic, Cellular, Molecular, and Functional Characterization of Stem Cells and Their Products According to Regulatory Requirements for FDA Approval

Authors

SOURALOVÁ, Tereza (203 Czech Republic, belonging to the institution), Daniela ŘEHÁKOVÁ (203 Czech Republic, belonging to the institution), Lenka TESAŘOVÁ (203 Czech Republic, belonging to the institution), Aleš HAMPL (203 Czech Republic, belonging to the institution) and Irena KOUTNÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

1. vyd. Singapore, Stem Cell Production, p. 185-203, 19 pp. Biomedicine & Life Sciences, 2022

Publisher

Springer, Singapore

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

10601 Cell biology

Country of publisher

Singapore

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

References:

RIV identification code

RIV/00216224:14110/22:00129662

Organization unit

Faculty of Medicine

ISBN

978-981-16-7588-1

Keywords in English

Stem cell production; Stem cell sterility; Stem cell clinical trials; Stem cell bioreactor; cGMP inspection

Tags

International impact, Reviewed
Změněno: 23/2/2024 09:18, Mgr. Marie Šípková, DiS.

Abstract

V originále

Stem cells have unique properties that make them an exceptional source for regenerative medicine. Various types of stem cells and their products are used for therapeutic purposes, and they differ in their morphology, molecular markers, and functional characteristics. Nevertheless, to comply with regulatory requirements, strict criteria must be fulfilled. Here, we provide a comprehensive overview of the characterization criteria for human mesenchymal stem cells (hMSCs), human neural stem cells (hNSCs), human pluripotent stem cells (hPSCs), and human hematopoietic stem cells (hHSCs) that constitute the starting material for cell therapy products.

Links

CZ.02.1.01/0.0/0.0/16_013/0001826, interní kód MU
(CEP code: EF16_013/0001826)
Name: CZECRIN_PRO PACIENTY - zavádění inovativních moderních terapií
Investor: Ministry of Education, Youth and Sports of the CR, Priority axis 1: Strengthening capacities for high-quality research
NV18-08-00412, research and development project
Name: Lidské embryonální kmenové buňky pro klinické aplikace: derivace a charakterizace
Investor: Ministry of Health of the CR